Laska E - Search Results

1

Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology.

Wolkin A, Sanfilipo M, Angrist B, Duncan E, Wieland S, Wolf AP, Brodie JD, Cooper TB, Laska E, Rotrosen JP. Wolkin A, et al. Among authors: laska e. Biol Psychiatry. 1994 Sep 1;36(5):317-25. doi: 10.1016/0006-3223(94)90629-7. Biol Psychiatry. 1994. PMID: 7993958 Clinical Trial.

2

Haloperidol blood levels and clinical effects.

Volavka J, Cooper T, Czobor P, Bitter I, Meisner M, Laska E, Gastanaga P, Krakowski M, Chou JC, Crowner M, et al. Volavka J, et al. Among authors: laska e. Arch Gen Psychiatry. 1992 May;49(5):354-61. doi: 10.1001/archpsyc.1992.01820050018002. Arch Gen Psychiatry. 1992. PMID: 1586270 Clinical Trial.

3

Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia.

Bartlett EJ, Wolkin A, Brodie JD, Laska EM, Wolf AP, Sanfilipo M. Bartlett EJ, et al. Among authors: laska em. Psychiatry Res. 1991 Oct;40(2):115-24. doi: 10.1016/0925-4927(91)90003-9. Psychiatry Res. 1991. PMID: 1763142

4

The spectral signature method for the analysis of PET brain images.

Levy AV, Laska E, Brodie JD, Volkow ND, Wolf AP. Levy AV, et al. Among authors: laska e. J Cereb Blood Flow Metab. 1991 Mar;11(2):A103-13. doi: 10.1038/jcbfm.1991.45. J Cereb Blood Flow Metab. 1991. PMID: 1997478

5

The metabolic centroid method for PET brain image analysis.

Levy AV, Brodie JD, Russell AG, Volkow ND, Laska E, Wolf AP. Levy AV, et al. Among authors: laska e. J Cereb Blood Flow Metab. 1989 Jun;9(3):388-97. doi: 10.1038/jcbfm.1989.58. J Cereb Blood Flow Metab. 1989. PMID: 2565910

6

Reproducibility of cerebral glucose metabolic measurements in resting human subjects.

Bartlett EJ, Brodie JD, Wolf AP, Christman DR, Laska E, Meissner M. Bartlett EJ, et al. Among authors: laska e. J Cereb Blood Flow Metab. 1988 Aug;8(4):502-12. doi: 10.1038/jcbfm.1988.91. J Cereb Blood Flow Metab. 1988. PMID: 3260593

7

Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms.

Wolkin A, Sanfilipo M, Duncan E, Angrist B, Wolf AP, Cooper TB, Brodie JD, Laska E, Rotrosen JP. Wolkin A, et al. Among authors: laska e. Am J Psychiatry. 1996 Mar;153(3):346-54. doi: 10.1176/ajp.153.3.346. Am J Psychiatry. 1996. PMID: 8610821 Clinical Trial.

8

Placebo washout in trials of antipsychotic drugs.

Volavka J, Cooper TB, Laska EM, Meisner M. Volavka J, et al. Among authors: laska em. Schizophr Bull. 1996;22(4):567-76. doi: 10.1093/schbul/22.4.567. Schizophr Bull. 1996. PMID: 8938911 Review.

9

Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction.

Brodie JD, Figueroa E, Laska EM, Dewey SL. Brodie JD, et al. Among authors: laska em. Synapse. 2005 Feb;55(2):122-5. doi: 10.1002/syn.20097. Synapse. 2005. PMID: 15543630 Clinical Trial.

10

Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.

Brodie JD, Case BG, Figueroa E, Dewey SL, Robinson JA, Wanderling JA, Laska EM. Brodie JD, et al. Among authors: laska em. Am J Psychiatry. 2009 Nov;166(11):1269-77. doi: 10.1176/appi.ajp.2009.08121811. Epub 2009 Aug 3. Am J Psychiatry. 2009. PMID: 19651710 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters